MINNETONKA, Minn. and
NEW YORK, May 13, 2019 /PRNewswire/ -- Lyfebulb LLC
and UnitedHealth Group (NYSE: UNH) invite patient entrepreneurs to
compete in "Empowering Patients: An Innovation Challenge," for the
second annual Lyfebulb and UnitedHealth Group Innovation
Award.
This year's challenge will recognize the top patient
entrepreneurs developing innovative ideas for better management of
depression and anxiety using health care information technology,
medical devices, diagnostics, consumer products or
services.
Eligible companies are those that are founded or led by a
patient entrepreneur: someone who has been personally affected by
depression or anxiety (themselves or through a loved one) and who
develops a product or service to address an unmet need identified
through personal experience. Companies based in the United States or Canada (excluding Quebec) are eligible to apply. The
application, detailed rules and eligibility criteria can be found
at click here. Applications are open until 11:59pm EST on May 31, 2019.
"Depression and anxiety are issues that particularly affect
people living with chronic disease," said Dr. Karin Hehenberger, founder and CEO of Lyfebulb.
"We are honored to work with UnitedHealth Group on an issue that
affects so many people in our community and nationwide. We are
eager to tap into the unique insights that patients have, and
leverage those to identify user-driven solutions by patient
entrepreneurs for issues they face."
A joint steering committee composed of Lyfebulb and UnitedHealth
Group executives will conduct a thorough sourcing and screening
process, and select 10 finalists who will be invited to the
Empowering Patients event July 23-24,
2019, at UnitedHealth Group's headquarters in Minnetonka. There, the finalists will pitch
their solutions to a panel of experts (a jury) from the business,
medical and patient communities. The jury will award a $25,000 prize to the company with the most
innovative and impactful solution at the closing ceremony.
"Depression and anxiety weave through all areas of disease –
chronic and acute – yet they are understudied and underserved in
terms of dialogue and solutions today in the United States," said Gene Baker, Ph.D., a research fellow at
UnitedHealth Group. "We are grateful for the opportunity to partner
with Lyfebulb and look forward to hearing from patients and
entrepreneurs to learn more about the innovative, patient-driven
solutions to help people living with depression and chronic
disease."
About Lyfebulb
Lyfebulb is a chronic disease-focused,
patient empowerment platform that connects patients and industry
(manufacturers and payers) to support user-driven innovation.
Lyfebulb promotes a healthy, take-charge lifestyle for those
affected by chronic disease. Grounded with its strong foundation in
diabetes, the company has expanded disease states covered into
cancer, inflammatory bowel disease, multiple sclerosis and
depression/anxiety.
See www.lyfebulb.com, Facebook, Twitter, Instagram, Karin
Hehenberger LinkedIn, and Lyfebulb LinkedIn.
About UnitedHealth Group
UnitedHealth Group (NYSE:
UNH) is a diversified health care company dedicated to helping
people live healthier lives and helping to make the health system
work better for everyone. UnitedHealth Group offers a broad
spectrum of products and services through two distinct platforms:
UnitedHealthcare, which provides health care coverage and benefits
services; and Optum, which provides information and
technology-enabled health services. For more information, visit
UnitedHealth Group at http://www.unitedhealthgroup.com/ or follow
@UnitedHealthGrp on Twitter.
Contact:
Lyfebulb
Karin
Hehenberger, M.D., Ph.D., CEO
917-575-0210; Karin@lyfebulb.com
UnitedHealth Group
Tyler
Mason
424-333-6122, tyler.mason@uhg.com
View original content to download
multimedia:http://www.prnewswire.com/news-releases/lyfebulb-and-unitedhealth-group-launch-second-annual-innovation-challenge-for-patient-entrepreneurs-300848565.html
SOURCE Lyfebulb